E-LIB Suche - Ergebnisse für: Tricta, F.

1

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION TH..:

Piga, A. ; Sheth, S. ; Kattamis, A....
HemaSphere. 6 (2022) - p. 1392-1393 , 2022

Link: https://doi.org/10.1097/..

2

S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INF..:

Elalfy, M ; El-Beshlawy, A ; Adly, A...
HemaSphere. 6 (2022) - p. 12-13 , 2022

Link: https://doi.org/10.1097/..

3

S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFET..:

Inusa, B ; Hamdy, M ; El-Beshlawy, A...
HemaSphere. 6 (2022) - p. 10-11 , 2022

Link: https://doi.org/10.1097/..

4

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATI..:

Inusa, B ; Hamdy, M ; El-Beshlawy, A...
HemaSphere. 6 (2022) - p. 8-8 , 2022

Link: https://doi.org/10.1097/..

5

P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WI..:

Tricta, F. ; Fradette, C. ; Temin, N....
HemaSphere. 6 (2022) - p. 1439-1440 , 2022

Link: https://doi.org/10.1097/..

6

RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF D..:

Hamdy, M ; El-Beshlawy, A ; Ebeid, FS...
Hematology, Transfusion and Cell Therapy. 44 (2022) - p. S338-S339 , 2022

Link: https://doi.org/10.1016/..

7

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THER..:

Kattamis, A. ; Kwiatkowski, J. ; Tricta, F....
HemaSphere. 6 (2022) - p. 2101-2102 , 2022

Link: https://doi.org/10.1097/..

8

LONG-TERM SAFETY AND EFFICACY OF DEFERIPRONE FOR THE TREATM..:

Verissimo, MPA ; Elalfy, MS ; Hamdy, M...
Hematology, Transfusion and Cell Therapy. 43 (2021) - p. S23-S24 , 2021

Link: https://doi.org/10.1016/..

9

Sickle Cell Disease: New Opportunities and Challenges in Af..:

Makani, J. ; Ofori-Acquah, S. F. ; Nnodu, O....
The Scientific World Journal. 2013 (2013) 1 - p. , 2013

Link: https://doi.org/10.1155/..

10

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THER..:

Kattamis, A ; Kwiatkowski, J ; Tricta, F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431642/. , 2022

Link: http://www.ncbi.nlm.nih...

11

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION TH..:

Piga, A ; Sheth, S ; Kattamis, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429506/. , 2022

Link: http://www.ncbi.nlm.nih...

12

P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WI..:

Tricta, F ; Fradette, C ; Temin, N...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429256/. , 2022

Link: http://www.ncbi.nlm.nih...

13

S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INF..:

Elalfy, M ; El-Beshlawy, A ; Adly, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811868/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Evaluation of the effectiveness and safety of deferiprone c..:

Maggio, A ; Kattamis, A ; Felisi, M...
https://discovery.ucl.ac.uk/id/eprint/10095160/1/thelancethaematology-D-20-00039_R4%20%282%29.pdf. , 2020

Link: https://discovery.ucl.ac..

15

Brain iron chelation by deferiprone in a phase 2 randomised..:

Martin-Bastida, A ; Ward, RJ ; Newbould, R...
Scientific Reports. , 2017

Link: http://hdl.handle.net/10..